Synthetic double-stranded RNAs are adjuvants for the induction of T helper 1 and humoral immune responses to human papillomavirus in rhesus macaques.
Toll-like receptor (TLR) ligands are being considered as adjuvants for the induction of antigen-specific immune responses, as in the design of vaccines. Polyriboinosinic-polyribocytoidylic acid (poly I:C), a synthetic double-stranded RNA (dsRNA), is recognized by TLR3 and other intracellular receptors. Poly ICLC is a poly I:C analogue, which has been stabilized against the serum nucleases that are present in the plasma of primates. Poly I:C(12)U, another analogue, is less toxic but also less stable in vivo than poly I:C, and TLR3 is essential for its recognition. To study the effects of these compounds on the induction of protein-specific immune responses in an animal model relevant to humans, rhesus macaques were immunized subcutaneously (s.c.) with keyhole limpet hemocyanin (KLH) or human papillomavirus (HPV)16 capsomeres with or without dsRNA or a control adjuvant, the TLR9 ligand CpG-C. All dsRNA compounds served as adjuvants for KLH-specific cellular immune responses, with the highest proliferative responses being observed with 2 mg/animal poly ICLC (p = 0.002) or 6 mg/animal poly I:C(12)U (p = 0.001) when compared with immunization with KLH alone. Notably, poly ICLC -- but not CpG-C given at the same dose -- also helped to induce HPV16-specific Th1 immune responses while both adjuvants supported the induction of strong anti-HPV16 L1 antibody responses as determined by ELISA and neutralization assay. In contrast, control animals injected with HPV16 capsomeres alone did not develop substantial HPV16-specific immune responses. Injection of dsRNA led to increased numbers of cells producing the T cell-activating chemokines CXCL9 and CXCL10 as detected by in situ hybridization in draining lymph nodes 18 hours after injections, and to increased serum levels of CXCL10 (p = 0.01). This was paralleled by the reduced production of the homeostatic T cell-attracting chemokine CCL21. Thus, synthetic dsRNAs induce an innate chemokine response and act as adjuvants for virus-specific Th1 and humoral immune responses in nonhuman primates.
Stahl-Hennig
Christiane
C
Laboratory of Infection Models, German Primate Center, Göttingen, Germany.
Eisenblätter
Martin
M
Jasny
Edith
E
Rzehak
Tamara
T
Tenner-Racz
Klara
K
Trumpfheller
Christine
C
Salazar
Andres M
AM
Uberla
Klaus
K
Nieto
Karen
K
Kleinschmidt
Jürgen
J
Schulte
Reiner
R
Gissmann
Lutz
L
Müller
Martin
M
Sacher
Anna
A
Racz
Paul
P
Steinman
Ralph M
RM
Uguccioni
Mariagrazia
M
Ignatius
Ralf
R
D000276:Adjuvants, Immunologic / Q000494:pharmacology*; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood / Q000276:immunology; D000917:Antibody Formation / Q000276:immunology*; D000956:Antigens, Viral / Q000276:immunology; D054421:Chemokine CCL21 / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D054357:Chemokine CXCL10 / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D054370:Chemokine CXCL9 / Q000096:biosynthesis / Q000097:blood / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006433:Hemocyanins / Q000276:immunology; D052162:Human papillomavirus 16 / Q000276:immunology*; D008253:Macaca mulatta; D053918:Papillomavirus Vaccines / Q000276:immunology; D012330:RNA, Double-Stranded / Q000276:immunology*; D018417:Th1 Cells / Q000276:immunology*; D051217:Toll-Like Receptor 9 / Q000276:immunology / Q000378:metabolism
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D000956:Antigens, Viral; D054421:Chemokine CCL21; D054357:Chemokine CXCL10; D054370:Chemokine CXCL9; D053918:Papillomavirus Vaccines; D012330:RNA, Double-Stranded; D051217:Toll-Like Receptor 9; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin